Eye-Drug Compounder Can't Dodge Allergan Suit
A California federal judge on Tuesday kept alive Allergan's false advertising suit against a large drug compounder, saying there are sufficient allegations the compounder is manufacturing eye medicines without adhering to...To view the full article, register now.
Already a subscriber? Click here to view full article